Perez, Jaime Rubio, Roberto Hernández, Yolanda Lage, Ana Belén Rupérez, Eva Ruiz, Tatiana Hernández, Bernard Doger, Jesús Garcia-Foncillas, and Víctor Moreno</p. “Posterior Reversible Encephalopathy Syndrome (PRES) in a Patient Treated With a Novel Combination Treatment With Anti PDL1 Antibody (Durvalumab) and VEGFR2 Antibody (Ramucirumab)”. Archives of Clinical and Medical Case Reports 4, no. 1 (January 2, 2020): 8–14. Accessed June 15, 2026. https://fortunejournals.org/ojs/index.php/acmcr/article/view/22266.